Mednow Announces Executive Appointments to Accelerate its Institutional Services Business
- Anthony Perlman hired as Senior Vice President, Benefits Strategy, to lead development of pharmacy and healthcare technology services to Canadian institutional market
- Dave Marantz appointed Chief Revenue Officer to manage national sales to institutional clients
Toronto, ON. (September 28, 2021) – Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce that the Company has made two executive hires, bolstering its institutional services business which seeks to provide pharmacy and healthcare solutions to employers, insurers, consulting firms, financial advisors and brokers. The Company announced on May 17, 2021, that it had signed its first institutional client, the Police Pensioners Association of Ontario. Mednow’s institutional business is targeting large pools of clients through employers and third-party benefits providers to provide its digital pharmacy and healthcare offering to plan members and assist plan sponsors at reducing their total healthcare costs.
Anthony Perlman has been appointed Senior Vice President, Benefits Strategy. In this role, Anthony will lead the development of Mednow’s pharmacy and healthcare technology services business to the Canadian institutional market. Anthony has over 30 years of experience in the insurance, consulting, and healthcare technology fields, including experience with Aon, Hewitt, Towers Watson, and League. He has held numerous leadership roles focusing on business development and multidisciplinary teams working with clients on developing their health and wellbeing strategies.
Dave Marantz has been appointed Chief Revenue Officer. Dave brings more than a decade of both sales and strategy experience at leading HR, benefits and health technology companies. Most recently, Dave acted as National Sales Director at League Health, a leading Toronto-based health benefits technology company, where he successfully contributed over $5 million of annual recurring revenue with Canada’s preeminent employers. Dave also helped to grow channel partnerships with insurance carriers, HR firms and benefits advisors. Dave previously held both sales and solution consulting positions at leading HR software providers including Rise, Dayforce and Ceridian.
“Building a successful institutional business is critical to executing our long-term strategy. Our institutional platform allows us to add large groups of patients to our platform, lower Mednow’s cost of customer acquisition, accelerate revenue growth and more quickly position Mednow as a household name in Canadian healthcare,” said Karim Nassar, CEO of Mednow.
About Mednow Inc.
Mednow is a healthcare technology company offering virtual access with exceptional care. Designed with access and quality care in mind, Mednow.ca provides virtual pharmacy and telemedicine services, as well as doctor home visits, with convenience and through an interdisciplinary approach to healthcare that is focused on the patient experience. Mednow’s services include free at-home delivery of medications, a user-friendly interface for easy upload, transfer and refill of prescriptions, access to healthcare professionals through an intuitive chat experience, a specialized PillSmart™ system that packages prescriptions and vitamins by date and time, and doctor consultations.
Investor Relations Contact:
Benjamin Ferdinand, Chief Financial Officer
Marc Charbin, Investor Relations
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements:
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, are forward-looking statements and contain forward-looking information, including statements relating to: anticipated results and benefits arising from Mednow’s institutional business. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including that the Company will be able to complete the launch of Mednow Virtual Care in the anticipated timeframe and the Company’s expectations regarding the results and benefits arising from Mednow Virtual Care. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, that the Company will not be able to complete the transactions contemplated in this news release or in the anticipated time frames, that actual results and benefits arising from Mednow Virtual Care may not be as anticipated by management, and other risk factors set out in the Company’s final long form prospectus dated February 26, 2021 available for review on the Company’s profile at www.sedar.com. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.